Kussmann, M., Karer, M., Obermueller, M., Schmidt, K., Barousch, W., Moser, D., . . . Lagler, H. (2018). Emergence of a dalbavancin induced glycopeptide/lipoglycopeptide non-susceptible Staphylococcus aureus during treatment of a cardiac device-related endocarditis. Emerg Microbes Infect.
Citação norma ChicagoKussmann, Manuel, et al. "Emergence of a Dalbavancin Induced Glycopeptide/lipoglycopeptide Non-susceptible Staphylococcus Aureus During Treatment of a Cardiac Device-related Endocarditis." Emerg Microbes Infect 2018.
Citação norma MLAKussmann, Manuel, et al. "Emergence of a Dalbavancin Induced Glycopeptide/lipoglycopeptide Non-susceptible Staphylococcus Aureus During Treatment of a Cardiac Device-related Endocarditis." Emerg Microbes Infect 2018.